1. 1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients. (September 2015) Authors: Bando, H.; Masuda, N.; Nakamura, R.; Kondo, N.; Kuroi, K.; Akiyoshi, S.; Ohtani, S.; Toshimi, T.; Inoue, K.; Yanagida, Y.; Ishiguro, H.; Shimizu, S.; Aogi, K.; Amano, S.; Ozaki, S.; Iguchi-Manaka, A.; Kasai, H.; Morita, S.; Kataoka, T.R.; Toi, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1955 Primary systemic therapy by dual HER2 blockage with lapatinib (La) + trastuzumab (T) for Japanese patients (pts) with HER2+ breast cancer (BC): Association of La toxicity and dose with treatment efficacy. (September 2015) Authors: Yamashita, T.; Masuda, N.; Yamamoto, N.; Kondo, N.; Bando, H.; Akiyoshi, S.; Ohtani, S.; Takano, T.; Inoue, K.; Fujisawa, T.; Ishiguro, H.; Nakayama, H.; Aogi, K.; Amano, S.; Ozaki, H.; Yasojima, H.; Kasai, H.; Kataoka, T.R.; Morita, S.; Toi, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anthracycline followed by trastuzumab is still one of treatment options for small tumor with node-negative HER2-positive breast cancer. (March 2019) Authors: Akiyoshi, S.; Kobayashi, K.; Kobayashi, T.; Hosonaga, M.; Kitagawa, D.; Ito, T.; Ueno, T.; Ohno, S. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinicopathological factors and prognosis according to subtype in elderly breast cancer patients older than 75-years-old. (March 2017) Authors: Ishida, M.; Akiyoshi, S.; Ijichi, H.; Masuda, T.; Tanaka, J.; Nakamura, Y.; Tokunaga, E. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P027 The analysis of cytogenetic intra-tumoral heterogeneity in squamous cell carcinoma of the breast. (March 2015) Authors: Oikawa, M.; Igawa, A.; Ishida, M.; Nakamura, Y.; Nishimura, S.; Koga, C.; Akiyoshi, S.; Koi, Y.; Taguchi, K.; Ohno, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer. (April 2023) Authors: Koh, S.; Koi, Y.; Tajiri, W.; Kawasaki, J.; Akiyoshi, S.; Nakamura, Y.; Koga, C.; Tokunaga, E. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P168 Time-to-failure in 1st-line endocrine therapy with ER+/HER2−metastatic breast cancer. (March 2015) Authors: Nishimura, S.; Akiyoshi, S.; Koga, C.; Oikawa, M.; Nskamura, Y.; Ishida, M.; Ohno, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P172 Different incidence of brain metastasis according to HER2 expression level in patients with triple negative breast cancer. (April 2023) Authors: Koi, Y.; Koh, S.; Tajiri, W.; Kawasaki, J.; Akiyoshi, S.; Koga, C.; Nakamura, Y.; Taguchi, K.; Tokunaga, E. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P172 Prognosis of hormone receptor positive recurrent breast cancer during endocrine therapy. (March 2015) Authors: Akiyoshi, S.; Oikawa, M.; Koi, Y.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.; Ohno, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P280 Differentiation between luminal-HER2 and HER2-enriched breast cancer in clinical course. (March 2015) Authors: Koi, Y.; Akiyoshi, S.; Oikawa, M.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.; Ohno, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗